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Background The antiarrhythmic effects of sodium channel and calcium channel blockers are known to be rate dependent. Little is known about the rate-dependent effect of adenosine on human atrioventricular (AV) nodal conduction. The purpose of this study was to determine whether the negative dromotropic effect of adenosine is dependent on heart rate.
Methods and Results Atrial pacing at 20-millisecond increments decreasing stepwise was performed, and the curves that relate the AH interval to the atrial pacing cycle length were analyzed. The change in AV nodal function was evaluated in three protocols: (1) In 8 group 1A and 6 group 1B patients, an intravenous infusion of adenosine at a dose of 140 and 320 gg * kg`1 min-m was given, respectively; (2) a bolus injection of a fixed dose of adenosine was given to 12 group 2A patients without and 6 group 2B patients with propranolol (0.1 mg/kg) treatment; and (3) in 12 group 3 patients, the AV nodal function was evaluated after intravenous propranolol (0.05 mg/kg) and after subsequent intravenous aminophylline (loading dose, 5 mg/kg; maintenance dose, 0.9 mg* kg.* h-1). No significant depression of AV nodal function could be demonstrated during intravenous infusion of adenosine. The bolus injection of adenosine could prolong the AH interval, which was dependent on heart rate and more significant at a shorter pacing cycle length. Intravenous propranolol significantly depressed the AV nodal conduction and shifted the curves of the AH interval versus the pacing cycle length to the right. Subsequent intravenous aminophylline shortened the AV nodal conduction time, however, in a rate-independent manner.
Conclusions The negative dromotropic effects induced by intravenous bolus injection of adenosine became more pronounced at fast atrial pacing rates. These results indicate that adenosine causes rate-dependent prolongation of AV nodal conduction in humans. (Circulation. 1994; 90:1832 -1839 Key Words * adenosine * conduction * tachycardia c atrioventricular node A denosine is an endogenous nucleoside with potent cardiac electrophysiological effects on the sinus node and atrioventricular (AV) node.12 Clinically, intravenous adenosine depresses AV nodal conduction and can be used to terminate most of the supraventricular tachycardias that involve the AV node as part of the reentrant circuit.34 The negative dromotropic effects of adenosine are believed to be mediated mainly by a receptor-effector complex that links the adenosine A, receptor to open the specific acetylcholine/adenosine-regulated potassium channels by the activation of inhibitory G protein. 5 Ideally, a drug used to treat reentrant tachycardia will demonstrate maximal effects on conduction and refractoriness during tachycardia but will have minimal effects at slow heart rates. 6 Previous studies in nerve and cardiac cells have characterized the use-or frequency-dependent action of local anesthetic agents,7-10 thereby leading to the evolution of the modulated receptor hypothesis.1""2 The characteristic frequency-dependent effects of calcium channel blockers13'14 and amiodarone"5 in human AV nodal conduction have also been described. Recently, the effects of adenosine on rate-dependent AV nodal function were demonstrated by Nayebpour et al16 in rabbit and guinea pig heart preparations. Since the great interspecies variation of the effects of adenosine on AV nodal function was reported previously,17 little is known about whether its rate-dependent effects were present in humans.18 Because the antiarrhythmic agent adenosine has been used widely to treat tachyarrhythmias, a better understanding of its rate-dependent action is necessary and important. We therefore designed the present study to evaluate whether adenosine-induced negative dromotropism in humans is related to heart rate.
Change in heart rate affects many facets of AV nodal electrophysiological properties.19-22 A variety of approaches have been used to characterize the ratedependent properties of the AV node.23-25 Since the negative dromotropic effects of intravenous adenosine are extremely short, the details of AV nodal properties cannot be examined thoroughly when an intravenous bolus injection of adenosine26 is applied. Therefore, we selected prolongation of the AV nodal conduction time (AH interval) as the indicator of negative dromotropism of adenosine. Our specific goal for this study was to determine the extent to which adenosine effects on AV nodal conduction are related to changes in heart rate.
Methods

Patient Population
Patients referred for electrophysiological evaluation of symptomatic or suspected cardiac arrhythmias were selected.
Patients who had a normal distribution of both antegrade Wenckebach cycle length and effective refractory periods of the AV node and atrium as described by Josephson and Seides27 were included. Patients with any of the following characteristics were excluded from the study: dual AV nodal physiology during incremental atrial pacing or atrial extrastimuli,28 preexcitation during electrophysiological study,29 or symptomatic heart failure.
Electrophysiological Study
All studies were performed with patients in an unsedated, fasting state after informed consent had been obtained. None of the patients had received any antiarrhythmic agents or medications known to interfere with the effects of adenosine. By conventional methods, three 6F quadripolar electrode catheters were introduced into the right femoral vein and advanced to the high right atrium, right AV junction, and right ventricular apex for recording and stimulation.30'31 Intracardiac ECGs were filtered at 30 to 500 Hz, simultaneously displayed with three surface ECG leads (I, II, and V,) on a multichannel oscilloscope (Electronics for Medicine VR-16), and simultaneously recorded on photosensitive paper at 100 mm/s. Stimulation was performed with a programmable stimulator (Bloom Associates). Stimuli were delivered as rectangular pulses of 2-millisecond duration at 2x diastolic threshold. In addition to the routine electrophysiological study, the following study protocol was performed in all patients. Incremental high right atrial pacing for 2 (5) To determine whether endogenous adenosine plays a role in the genesis of modulatory effects on AV nodal conduction properties at fast pacing heart rates, the third study protocol was performed. In 12 group 3 patients (6 men, 6 women; mean age, 43±9 years), the electrophysiological properties of the AV node were studied in the control state and 10 minutes after intravenous propranolol injection at a dose of 0.05 mg/kg body wt; immediately after the propranolol study, aminophylline (theophylline ethylenediamine) at a loading dose of 5 mg/kg was given intravenously for 5 minutes and was followed by a continuous intravenous infusion at a dose of 0.9 mg* kg.* h'. The electrophysiological study was repeated during the maintenance aminophylline infusion. A blood sample was also taken to document theophylline serum concentration measured by fluorescence polarization immunoassay (TDX, Abbott Laboratories).32 The AH intervals at each different pacing cycle length were compared in the control state, after intravenous propranolol, and during aminophylline infusion.
The actions of the intravenously injected adenosine were short and rapid; its effects may depend on speed of injection and the patient's circulation time. To assess the intraindividual variation of adenosine effects, 6 patients (4 men, 2 women; mean age, 42±8 years) were studied as follows: Under compatible and constant pacing cycle lengths, intravenous bolus injection of adenosine at a fixed dose of 1 mg was given to each patient and followed by rapid saline flush. This procedure was repeated five times for each patient. The delay for each procedure was 5 minutes. The maximal prolongation of AH interval induced by adenosine was observed and compared for each procedure.
Statistical Analysis
The curves of the AH interval versus the pacing cycle length were assessed to determine whether the difference in AH intervals between drug and control curves was greater at the shorter pacing cycle length tested. Alterations in pacing cycle length result in a complex process that includes changes in drug dissociation between beats and in drug association occur (Tables 1 and 2 ). Although the functional refractory periods of the atrium precluded determination of the jug kg. * min-. In the control state and during intravenous infusion of adenosine, the AH interval increased as the pacing cycle length decreased; however, the curves of the AH interval versus the pacing cycle length were almost identical (Fig 1) . The time constants for the slow and fast components of the control curve were 716±12 and 36±5 milliseconds, respectively, whereas those of the adenosine infusion curve were 720+10 and 39±6 milliseconds, respectively, in group 1A patients. Meanwhile, the time constants for the slow and fast components of the control curve were 725±11 and 35±7 milliseconds, respectively, whereas those of the adenosine infusion curve were 729±10 and 34±9 milliseconds, respectively, in group 1B patients. These results indicate that no significant modulation of the rate-dependent AV nodal conduction properties could be demonstrated during intravenous infusion of adenosine at the dose we used in this study. The higher dose of adenosine was limited by side effects that were not tolerated by patients. All six group 1B patients had chest tightness, nausea, and headache that subsided after adenosine infusion was terminated. One group 1B patient was noted to develop bronchial asthma that was reversed by intravenous aminophylline injection. AH interval induced by adenosine injection after propranolol treatment increased more significantly as the pacing cycle length decreased. These results indicate that in the presence of propranolol treatment, the effects of adenosine on AV nodal conduction were still dependent on heart rate. The mean dose of bolus injection of adenosine for each group 2B patient was 30.2± 12.4 gg/kg.
Effects of Intravenous Propranolol and Aminophylline (Group 3)
Intravenous propranolol significantly prolonged the sinus cycle length (718±109 versus 672±120 milliseconds), the 1:1 AV node conduction cycle length (362±42 versus 329±21 milliseconds), and the effective refractory period of the AV node (310±37 versus 283±10 milliseconds). Compared with the effects of intravenous propranolol, intravenous aminophylline significantly shortened the basic sinus cycle length and the effective refractory period of the AV node (Table 3) . Fig 5 illustrates the effects of atrial pacing on the AH interval in a patient who received intravenous propranolol and subsequent intravenous aminophylline infusion. In the control state, the AH interval progressively increased as the pacing cycle length decreased. After intravenous propranolol, the AH interval also progressively increased when the pacing cycle length decreased. Of note, prolongation of the AH interval after intravenous propranolol, relative to the control state, became more pronounced as the pacing cycle length decreased. On the other hand, during intravenous infusion of aminophylline, prolongation of the AH interval induced by propranolol was shortened. The curve that relates the AH interval to the atrial pacing cycle length was smoothly shifted to the left compared with the curve of intravenous propranolol. The mean changes in AH interval induced by intravenous propranolol and aminophylline of all group ie, intravenous infusion and bolus injection of were used to demonstrate the adenosine i of the rate-dependent AV nodal conduction. dly, during the recommended intravenous in--,of adenosine (140 ,ugg kg`min-1)37.38 and gher dose (320 jugg kg`min-1), the negative ic effects of adenosine were not demonstrated electrophysiological study. In contrast, the and AV nodal conduction were slightly accelntravenous adenosine infusion (Tables 1 and  tions for these findings include the following: sine-induced augmentation of sympathetic was most likely caused by vasodilation in the vasculature37 as well as chemoreceptor activacarotid body.39 The sympathetic augmentation the negative dromotropic and chronotropic ntravenous infusion of adenosine. This augof sympathetic stimulation was compatible ndings that the sinus cycle length and blood ecreased during intravenous adenosine infukdenosine, on intravenous infusion in this have already been metabolized, thus becombefore reaching the AV node, and as a result e been inadequate to produce a significant omotropic response. 26 Further study may be o determine the minimal intravenous infusion nosine required to produce sustained inhibion AV nodal conduction. In addition, to e sympathetic reflex caused by adenosine, intravenous infusion of adenosine might be ler autonomic blockade. However, side effects tolerance levels should be considered. C indicates control; P, intravenous propranolol; A, intravenous aminophylline; and other abbreviations are the same as in Table 1 .
*p<.01.
Rate Dependency of Adenosine Effects
With the protocol of intravenous bolus injection, we demonstrated that adenosine-induced changes in AV node functional properties became more pronounced at rapid heart rates in the control state and after propranolol treatment. Compared with previous studies, these tachycardia-dependent AV nodal depressant properties could apply to calcium channel-blocking agents and vagal stimulation. 13, 14, 36 The intravenous bolus dose of adenosine used in this study was relatively small. Therefore, there were no significant negative dromotropic effects of adenosine at a slow heart rate. However, at a fast heart rate, the obvious AV nodal conduction delay Cycle Length (msec) could be demonstrated with the same dose of intravenous bolus injection of adenosine. If we chose the recommended bolus injection dose of adenosine (6 to 12 mg), AV nodal block would occur at slow and fast heart rates in most patients, and rate-dependent responses of AV nodal conduction to adenosine would not be able to be illustrated. The results from group 2A and 2B patients showed that with or without propranolol treatment, the modulation of exogenously injected adenosine on AV nodal conduction was rate dependent. These findings may indicate that the rate-dependent modulation of AV nodal conduction by intravenous injection of adenosine was caused mainly by direct adenosine effects, whereas the indirect antiadrenergic action of adenosine appeared to be insignificant in this study. propranolol were also demonstrated at a fast heart rate. This rate-dependent change in AV nodal conduction induced by f8-adrenergic blockade is compatible with previous reports.35 Of note, the finding that intravenous aminophylline shifted the AV nodal conduction curve to the left in a parallel pattern suggests that this left shift could be due to the antagonistic effects of endogenous adenosine and the sympathomimetic action induced by aminophylline. As reported by Belardinelli et al,44 at a low concentration of aminophylline the effects of aminophylline-stimulated release of catecholamines were not significant in isolated perfused guinea pig heart, and the main action of aminophylline was the selective antagonism to adenosine effects. In this study, if the left shift of the AV nodal conduction curve caused by aminophylline had been attributed to the antagonistic effects of endogenous adenosine, the parallel left shift of the curve that was not more conspicuous at shorter pacing lengths may suggest that the contributory effects of endogenous adenosine on AV nodal conduction were not observed at fast pacing rates. When we applied this finding to the results of group 2 patients, there was more evidence to indicate that the rate dependency of the negative dromotropic effect of adenosine in this study was caused mainly by the action of the exogenously injected adenosine. However, since aminophylline possesses multiple electrophysiological and hemodynamic effects,41 43 it is difficult to draw conclusions about the role of endogenous adenosine in rate-dependent negative dromotropism according to the results of this study. A more specific adenosine receptor antagonist should be used to explore this event in a future study.
Because this was an in vivo human study, the possibility of release of catecholamines induced by aminophylline, although the serum concentration was in the low range, could not be totally excluded. Therefore, another the effects of aminophylline-stimulated release of catecholamines, which in part reversed the depressive effects of AV nodal conduction induced by propranolol.
It is worth mentioning that the use-dependency phenomenon was seen primarily with drugs that were administered on a long-term basis. Interestingly, according to the results of our study, a drug such as adenosine that is rapidly metabolized after injection is still able to demonstrate rate-dependent effects on AV nodal conduction. The mechanisms through which adenosine induced negative dromotropism in a ratedependent manner certainly need to be clarified further.
Study Limitations
Several limitations of this study should be mentioned: (1) The number of patients evaluated in the present study was relatively small. Nevertheless, intravenous bolus injection of adenosine was constantly found to produce rate-dependent effects. Repetitive injection of adenosine and its accompanying side effects were unendurable and hence did not allow us to analyze more patient samples. (2) Since bolus injection of adenosine has a short half-life, it is difficult to measure all the functional parameters of the AV node. Thus, only the AV nodal conduction time was analyzed as the indicator of AV nodal function. (3) The dependency of adenosine effects on the speed of injection, circulation time, and the hemodynamic effects of different pacing heart rates may affect the concentration of adenosine that reaches the AV node. However, since the present study was a clinical investigation and the intraindividual variation of adenosine effects on AH interval proved not to be significant, we believe that the present findings of rate-dependent effects of adenosine on AV nodal conduction are credible. (4) Because propranolol is not a total autonomic blocker, changes in autonomic tone may occur during different pacing heart rates and interfere with the AV nodal conduction induced by adenosine. Despite the presence of residual autonomic tone, rate-dependent effects of adenosine were demonstrated. Also, these results can be applied clinically because most of the patients who receive intravenous adenosine for supraventricular tachycardia exhibit autonomic reflexes.
Clinical Consequences
Intravenous bolus injection of adenosine is the drug of choice for terminating supraventricular tachycardias that involve the AV node as part of the reentrant circuit. In this study, we demonstrate the rate-dependent effects of adenosine on human AV nodal conduction. The characteristic augmentation by tachycardia of AV nodal conduction prolongation caused by adenosine could result in enhanced antiarrhythmic action of adenosine during supraventricular tachycardia. In addition, after conversion of tachycardia, the response in adenosineinduced AV nodal depression will be reduced due to the slowed heart rate, which may contribute to adenosine's margin of safety in clinical application. Thus, an appropriate dose of adenosine might be available not only to terminate the sustained tachycardia but also to maintain proper AV nodal conduction without producing signifinterpretation of the left shift of the AV nodal conduction curve caused by aminophylline is that it was due to icant AV block or sinus pause after restoration of the sinus rhythm. 
